CSV export

Details about the neuroanatomical projections from ILA to ILA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71110 Infralimbic areaInfralimbic area strongPHAL
[...] dense terminal labeling in layers IVI of IL itself and in all layers of the ventral parts of the PL, with a preference for I and V.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Labeling patterns of an illustrative case of injections in the IL (n=4) are shown in Fig. 3A. All injections include both the superficial and deep layers (Fig. 3B). Collator note: IL as defined in this paper does not include the dorsal peduncular cortex.

Details about the neuroanatomical projections from ILA to PL

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71111 Infralimbic areaPrelimbic area strongPHAL
[...] dense terminal labeling in layers IVI of IL itself and in all layers of the ventral parts of the PL, with a preference for I and V. Collator note: Table 1 page 200 shows that layers I, III, V receive strong projections from ILA, while II and VI weak ones. We followed the results shown in Table 1.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71112 Infralimbic areaPrelimbic area strongPHAL
[...] dense terminal labeling in layers IVI of IL itself and in all layers of the ventral parts of the PL, with a preference for I and V. Collator note: Table 1 page 200 shows that layers I, III, V receive strong projections from ILA, while II and VI weak ones. We followed the results shown in Table 1.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71113 Infralimbic areaPrelimbic area strongPHAL
[...] dense terminal labeling in layers IVI of IL itself and in all layers of the ventral parts of the PL, with a preference for I and V. Collator note: Table 1 page 200 shows that layers I, III, V receive strong projections from ILA, while II and VI weak ones. We followed the results shown in Table 1.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71114 Infralimbic areaPrelimbic area light/moderatePHAL
Collator note: Table 1 page 200 shows that layers I, III, V receive strong projections from ILA, while II and VI weak ones. We followed the results shown in Table 1.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71115 Infralimbic areaPrelimbic area light/moderatePHAL
Collator note: Table 1 page 200 shows that layers I, III, V receive strong projections from ILA, while II and VI weak ones. We followed the results shown in Table 1.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Labeling patterns of an illustrative case of injections in the IL (n=4) are shown in Fig. 3A. All injections include both the superficial and deep layers (Fig. 3B). Collator note: IL as defined in this paper does not include the dorsal peduncular cortex.

Details about the neuroanatomical projections from ILA to ACAd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71116 Infralimbic areaAnterior cingulate area dorsal part lightPHAL
Additional labeling is present in the ... rostral parts of the ACv-d (slight). Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71117 Infralimbic areaAnterior cingulate area dorsal part lightPHAL
Additional labeling is present in the ... rostral parts of the ACv-d (slight). Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71118 Infralimbic areaAnterior cingulate area dorsal part lightPHAL
Additional labeling is present in the ... rostral parts of the ACv-d (slight). Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71119 Infralimbic areaAnterior cingulate area dorsal part lightPHAL
Additional labeling is present in the ... rostral parts of the ACv-d (slight). Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Labeling patterns of an illustrative case of injections in the IL (n=4) are shown in Fig. 3A. All injections include both the superficial and deep layers (Fig. 3B). Collator note: IL as defined in this paper does not include the dorsal peduncular cortex.

Details about the neuroanatomical projections from ILA to ACAv

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71120 Infralimbic areaAnterior cingulate area ventral part lightPHAL
Additional labeling is present in the ... rostral parts of the ACv-d (slight). Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71121 Infralimbic areaAnterior cingulate area ventral part lightPHAL
Additional labeling is present in the ... rostral parts of the ACv-d (slight). Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Labeling patterns of an illustrative case of injections in the IL (n=4) are shown in Fig. 3A. All injections include both the superficial and deep layers (Fig. 3B). Collator note: IL as defined in this paper does not include the dorsal peduncular cortex.

Details about the neuroanatomical projections from ILA to RSPv-a

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
73194 Infralimbic areaRetrosplenial area ventral part zone a not presentbiotinylated dextran amine (BDA)
Collator note: see Table 1 page 200. RSPv shows no projections to PL or ILA, therefore it is inferred that neither of its suparts has projections towards these two targets. See also Figure 2C for a reconstruction of all injections in this article.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Collator note: a compherensive set of small-sized injections was performed over the entire RSP, see Figure 2 page 198.

Details about the neuroanatomical projections from ILA to RSPv

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71124 Infralimbic areaRetrosplenial area ventral part not presentPHAL
Other areas of the cingulate cortex are practically devoid of fibers. Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Labeling patterns of an illustrative case of injections in the IL (n=4) are shown in Fig. 3A. All injections include both the superficial and deep layers (Fig. 3B). Collator note: IL as defined in this paper does not include the dorsal peduncular cortex.

Details about the neuroanatomical projections from ILA to RSPd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71122 Infralimbic areaRetrosplenial area dorsal part not presentPHAL
Other areas of the cingulate cortex are practically devoid of fibers. Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Labeling patterns of an illustrative case of injections in the IL (n=4) are shown in Fig. 3A. All injections include both the superficial and deep layers (Fig. 3B). Collator note: IL as defined in this paper does not include the dorsal peduncular cortex.

Details about the neuroanatomical projections from ILA to RSPv-b/c

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
73195 Infralimbic areaRetrosplenial area ventral part zone b/c not presentbiotinylated dextran amine (BDA)
Collator note: see Table 1 page 200. RSPv shows no projections to PL or ILA, therefore it is inferred that neither of its suparts has projections towards these two targets. See also Figure 2C for a reconstruction of all injections in this article.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Collator note: a compherensive set of small-sized injections was performed over the entire RSP, see Figure 2 page 198.

Details about the neuroanatomical projections from PL to ILA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71125 Prelimbic areaInfralimbic area strongPHAL
Injections into dorsal parts of PL (Fig. 4A, C) result in moderate to dense labeling in ACd and slight to moderate labeling in IL. In contrast, injections into ventral PL (Fig. 4B, D, E) result in slight to moderate labeling in ACd and dense labeling in IL.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Nine animals had injections confined to the PL cortex, with two representative cases shown in Fig. 4A, B. Collator note: see Figure 2C for the spatial location of injection sites.

Details about the neuroanatomical projections from PL to PL

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71126 Prelimbic areaPrelimbic area strongPHAL
[...] following PL injections terminal labeling is more widespread, localized in the PL [...]
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71127 Prelimbic areaPrelimbic area strongPHAL
[...] following PL injections terminal labeling is more widespread, localized in the PL [...]
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71128 Prelimbic areaPrelimbic area lightPHAL
[...] following PL injections terminal labeling is more widespread, localized in the PL [...]
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71129 Prelimbic areaPrelimbic area lightPHAL
[...] following PL injections terminal labeling is more widespread, localized in the PL [...]
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Nine animals had injections confined to the PL cortex, with two representative cases shown in Fig. 4A, B. Collator note: see Figure 2C for the spatial location of injection sites.

Details about the neuroanatomical projections from PL to ACAd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71133 Prelimbic areaAnterior cingulate area dorsal part strongPHAL
Injections into dorsal parts of PL (Fig. 4A, C) result in moderate to dense labeling in ACd and slight to moderate labeling in IL. In contrast, injections into ventral PL (Fig. 4B, D, E) result in slight to moderate labeling in ACd and dense labeling in IL. Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71134 Prelimbic areaAnterior cingulate area dorsal part strongPHAL
Injections into dorsal parts of PL (Fig. 4A, C) result in moderate to dense labeling in ACd and slight to moderate labeling in IL. In contrast, injections into ventral PL (Fig. 4B, D, E) result in slight to moderate labeling in ACd and dense labeling in IL. Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71135 Prelimbic areaAnterior cingulate area dorsal part lightPHAL
Injections into dorsal parts of PL (Fig. 4A, C) result in moderate to dense labeling in ACd and slight to moderate labeling in IL. In contrast, injections into ventral PL (Fig. 4B, D, E) result in slight to moderate labeling in ACd and dense labeling in IL. Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71136 Prelimbic areaAnterior cingulate area dorsal part lightPHAL
Injections into dorsal parts of PL (Fig. 4A, C) result in moderate to dense labeling in ACd and slight to moderate labeling in IL. In contrast, injections into ventral PL (Fig. 4B, D, E) result in slight to moderate labeling in ACd and dense labeling in IL. Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Nine animals had injections confined to the PL cortex, with two representative cases shown in Fig. 4A, B. Collator note: see Figure 2C for the spatial location of injection sites.

Details about the neuroanatomical projections from PL to ACAv

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71130 Prelimbic areaAnterior cingulate area ventral part strongPHAL
Following caudal PL injections a dense plexus of terminating fibers is present in ACv, whereas rostral PL injections give rise to sparse labeling this area (compare Fig. 4A with B). Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71131 Prelimbic areaAnterior cingulate area ventral part strongPHAL
Following caudal PL injections a dense plexus of terminating fibers is present in ACv, whereas rostral PL injections give rise to sparse labeling this area (compare Fig. 4A with B). Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71132 Prelimbic areaAnterior cingulate area ventral part lightPHAL
Following caudal PL injections a dense plexus of terminating fibers is present in ACv, whereas rostral PL injections give rise to sparse labeling this area (compare Fig. 4A with B). Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Nine animals had injections confined to the PL cortex, with two representative cases shown in Fig. 4A, B. Collator note: see Figure 2C for the spatial location of injection sites.

Details about the neuroanatomical projections from PL to RSPv-a

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71139 Prelimbic areaRetrosplenial area ventral part zone a lightPHAL
[....] caudal PL injections sparsely but consistently lead to terminal labeling in RSv-a, whereas rostral PL injections do not (compare Fig. 4A with B). Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
73196 Prelimbic areaRetrosplenial area ventral part zone a not presentbiotinylated dextran amine (BDA)
Collator note: see Table 1 page 200. RSPv shows no projections to PL or ILA, therefore it is inferred that neither of its suparts has projections towards these two targets. See also Figure 2C for a reconstruction of all injections in this article.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Nine animals had injections confined to the PL cortex, with two representative cases shown in Fig. 4A, B. Collator note: see Figure 2C for the spatial location of injection sites.

Details about the neuroanatomical projections from PL to RSPd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71137 Prelimbic areaRetrosplenial area dorsal part not presentPHAL
Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Nine animals had injections confined to the PL cortex, with two representative cases shown in Fig. 4A, B. Collator note: see Figure 2C for the spatial location of injection sites.

Details about the neuroanatomical projections from PL to RSPv-b/c

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71140 Prelimbic areaRetrosplenial area ventral part zone b/c not presentPHAL
Collator note: see Table 1 page 200. RSPv-a is the single subregion of RSP labeled by (caudal) injections in the PL.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
73197 Prelimbic areaRetrosplenial area ventral part zone b/c not presentbiotinylated dextran amine (BDA)
Collator note: see Table 1 page 200. RSPv shows no projections to PL or ILA, therefore it is inferred that neither of its suparts has projections towards these two targets. See also Figure 2C for a reconstruction of all injections in this article.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Nine animals had injections confined to the PL cortex, with two representative cases shown in Fig. 4A, B. Collator note: see Figure 2C for the spatial location of injection sites.

Details about the neuroanatomical projections from ACAv to ILA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71141 Anterior cingulate area ventral partInfralimbic area not presentPHAL
Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71142 Anterior cingulate area ventral partInfralimbic area lightPHAL
Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71143 Anterior cingulate area ventral partInfralimbic area lightPHAL
Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71144 Anterior cingulate area ventral partInfralimbic area lightPHAL
Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: A total of 10 cases with injections in the ACv were examined, with two representative cases shown in Fig. 5A, B.

Details about the neuroanatomical projections from ACAv to PL

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71145 Anterior cingulate area ventral partPrelimbic area lightPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71146 Anterior cingulate area ventral partPrelimbic area lightPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71147 Anterior cingulate area ventral partPrelimbic area lightPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71148 Anterior cingulate area ventral partPrelimbic area lightPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71149 Anterior cingulate area ventral partPrelimbic area strongPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71150 Anterior cingulate area ventral partPrelimbic area strongPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71151 Anterior cingulate area ventral partPrelimbic area lightPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71152 Anterior cingulate area ventral partPrelimbic area lightPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71153 Anterior cingulate area ventral partPrelimbic area lightPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: A total of 10 cases with injections in the ACv were examined, with two representative cases shown in Fig. 5A, B.

Details about the neuroanatomical projections from ACAv to ACAd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71162 Anterior cingulate area ventral partAnterior cingulate area dorsal part strongPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71163 Anterior cingulate area ventral partAnterior cingulate area dorsal part strongPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71164 Anterior cingulate area ventral partAnterior cingulate area dorsal part lightPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71165 Anterior cingulate area ventral partAnterior cingulate area dorsal part strongPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71166 Anterior cingulate area ventral partAnterior cingulate area dorsal part strongPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71167 Anterior cingulate area ventral partAnterior cingulate area dorsal part lightPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71168 Anterior cingulate area ventral partAnterior cingulate area dorsal part lightPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71169 Anterior cingulate area ventral partAnterior cingulate area dorsal part lightPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: A total of 10 cases with injections in the ACv were examined, with two representative cases shown in Fig. 5A, B.

Details about the neuroanatomical projections from ACAv to ACAv

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71154 Anterior cingulate area ventral partAnterior cingulate area ventral part strongPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71155 Anterior cingulate area ventral partAnterior cingulate area ventral part strongPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71156 Anterior cingulate area ventral partAnterior cingulate area ventral part lightPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71157 Anterior cingulate area ventral partAnterior cingulate area ventral part strongPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71158 Anterior cingulate area ventral partAnterior cingulate area ventral part strongPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71159 Anterior cingulate area ventral partAnterior cingulate area ventral part strongPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71160 Anterior cingulate area ventral partAnterior cingulate area ventral part strongPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71161 Anterior cingulate area ventral partAnterior cingulate area ventral part lightPHAL
Superficially placed injections predominantly result in labeling in layers I and III of PL, ACv and ACd, whereas injections into the deeper layers preferentially result in tracer deposit in layers I and V of these regions (Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: A total of 10 cases with injections in the ACv were examined, with two representative cases shown in Fig. 5A, B.

Details about the neuroanatomical projections from ACAd to ILA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71170 Anterior cingulate area dorsal partInfralimbic area not presentPHAL
Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71171 Anterior cingulate area dorsal partInfralimbic area lightPHAL
Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Eleven animals had injections confined to the ACd, three representative cases of which are shown in Fig. 6AC.

Details about the neuroanatomical projections from ACAd to PL

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71172 Anterior cingulate area dorsal partPrelimbic area lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71173 Anterior cingulate area dorsal partPrelimbic area lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71174 Anterior cingulate area dorsal partPrelimbic area lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71175 Anterior cingulate area dorsal partPrelimbic area strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71176 Anterior cingulate area dorsal partPrelimbic area strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71177 Anterior cingulate area dorsal partPrelimbic area lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71178 Anterior cingulate area dorsal partPrelimbic area lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71179 Anterior cingulate area dorsal partPrelimbic area lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Eleven animals had injections confined to the ACd, three representative cases of which are shown in Fig. 6AC.

Details about the neuroanatomical projections from ACAd to ACAd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71190 Anterior cingulate area dorsal partAnterior cingulate area dorsal part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71191 Anterior cingulate area dorsal partAnterior cingulate area dorsal part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71192 Anterior cingulate area dorsal partAnterior cingulate area dorsal part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71193 Anterior cingulate area dorsal partAnterior cingulate area dorsal part lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71194 Anterior cingulate area dorsal partAnterior cingulate area dorsal part lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71195 Anterior cingulate area dorsal partAnterior cingulate area dorsal part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71196 Anterior cingulate area dorsal partAnterior cingulate area dorsal part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71197 Anterior cingulate area dorsal partAnterior cingulate area dorsal part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71198 Anterior cingulate area dorsal partAnterior cingulate area dorsal part lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Eleven animals had injections confined to the ACd, three representative cases of which are shown in Fig. 6AC.

Details about the neuroanatomical projections from ACAd to ACAv

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71180 Anterior cingulate area dorsal partAnterior cingulate area ventral part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71181 Anterior cingulate area dorsal partAnterior cingulate area ventral part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71182 Anterior cingulate area dorsal partAnterior cingulate area ventral part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71183 Anterior cingulate area dorsal partAnterior cingulate area ventral part lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71184 Anterior cingulate area dorsal partAnterior cingulate area ventral part lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71185 Anterior cingulate area dorsal partAnterior cingulate area ventral part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71186 Anterior cingulate area dorsal partAnterior cingulate area ventral part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71187 Anterior cingulate area dorsal partAnterior cingulate area ventral part lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71188 Anterior cingulate area dorsal partAnterior cingulate area ventral part lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71189 Anterior cingulate area dorsal partAnterior cingulate area ventral part lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Eleven animals had injections confined to the ACd, three representative cases of which are shown in Fig. 6AC.

Details about the neuroanatomical projections from ACAd to RSPv

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71199 Anterior cingulate area dorsal partRetrosplenial area ventral part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71200 Anterior cingulate area dorsal partRetrosplenial area ventral part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71201 Anterior cingulate area dorsal partRetrosplenial area ventral part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71202 Anterior cingulate area dorsal partRetrosplenial area ventral part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71203 Anterior cingulate area dorsal partRetrosplenial area ventral part lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71204 Anterior cingulate area dorsal partRetrosplenial area ventral part lightPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Eleven animals had injections confined to the ACd, three representative cases of which are shown in Fig. 6AC.

Details about the neuroanatomical projections from ACAd to RSPd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71205 Anterior cingulate area dorsal partRetrosplenial area dorsal part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71206 Anterior cingulate area dorsal partRetrosplenial area dorsal part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71207 Anterior cingulate area dorsal partRetrosplenial area dorsal part strongPHAL
Superficially placed injections preferentially label fibers in layers I and III of ACv+d and layers I and V of the RS (Fig. 6DG), whereas injections in the deep layers result in labeled fibers in layers I, III and V of ACd, layers I and V of PL, ACv and RSv and layer V of RSd (Fig. 6H, I; Table 1).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Eleven animals had injections confined to the ACd, three representative cases of which are shown in Fig. 6AC.

Details about the neuroanatomical projections from RSPv-a to ILA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
73190 Retrosplenial area ventral part zone aInfralimbic area not presentbiotinylated dextran amine (BDA)
Collator note: see Table 1 page 200. RSPv shows no projections to PL or ILA, therefore it is inferred that neither of its suparts has projections towards these two targets. See also Figure 2C for a reconstruction of all injections in this article.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Collator note: a compherensive set of small-sized injections was performed over the entire RSP, see Figure 2 page 198.

Details about the neuroanatomical projections from RSPv-a to PL

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71209 Retrosplenial area ventral part zone aPrelimbic area not presentbiotinylated dextran amine (BDA)
Collator note: case 0050, see Figure 7 page 203.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71211 Retrosplenial area ventral part zone aPrelimbic area not presentbiotinylated dextran amine (BDA)
Collator note: case 0579, see Figure 7 page 203.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
73192 Retrosplenial area ventral part zone aPrelimbic area not presentbiotinylated dextran amine (BDA)
Collator note: see Table 1 page 200. RSPv shows no projections to PL or ILA, therefore it is inferred that neither of its suparts has projections towards these two targets. See also Figure 2C for a reconstruction of all injections in this article.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Two representative cases of a total of 12 injections confined to the RSv are depicted in Fig. 7A, B. Collator note: cases 0080 and 05079, Figure 7, page 204.

Details about the neuroanatomical projections from RSPv-a to ACAd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71215 Retrosplenial area ventral part zone aAnterior cingulate area dorsal part strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71216 Retrosplenial area ventral part zone aAnterior cingulate area dorsal part strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71217 Retrosplenial area ventral part zone aAnterior cingulate area dorsal part strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Two representative cases of a total of 12 injections confined to the RSv are depicted in Fig. 7A, B. Collator note: cases 0080 and 05079, Figure 7, page 204.

Details about the neuroanatomical projections from RSPv-a to ACAv

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71212 Retrosplenial area ventral part zone aAnterior cingulate area ventral part strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71213 Retrosplenial area ventral part zone aAnterior cingulate area ventral part strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71214 Retrosplenial area ventral part zone aAnterior cingulate area ventral part strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Two representative cases of a total of 12 injections confined to the RSv are depicted in Fig. 7A, B. Collator note: cases 0080 and 05079, Figure 7, page 204.

Details about the neuroanatomical projections from RSPv-a to RSPd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71224 Retrosplenial area ventral part zone aRetrosplenial area dorsal part strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71225 Retrosplenial area ventral part zone aRetrosplenial area dorsal part strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Two representative cases of a total of 12 injections confined to the RSv are depicted in Fig. 7A, B. Collator note: cases 0080 and 05079, Figure 7, page 204.

Details about the neuroanatomical projections from RSPv-a to RSPv-b/c

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71218 Retrosplenial area ventral part zone aRetrosplenial area ventral part zone b/c strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71219 Retrosplenial area ventral part zone aRetrosplenial area ventral part zone b/c strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71220 Retrosplenial area ventral part zone aRetrosplenial area ventral part zone b/c strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Two representative cases of a total of 12 injections confined to the RSv are depicted in Fig. 7A, B. Collator note: cases 0080 and 05079, Figure 7, page 204.

Details about the neuroanatomical projections from RSPv-b/c to ILA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71208 Retrosplenial area ventral part zone b/cInfralimbic area not presentbiotinylated dextran amine (BDA)
Collator note: case 0050, see Figure 7 page 203.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71210 Retrosplenial area ventral part zone b/cInfralimbic area not presentbiotinylated dextran amine (BDA)
Collator note: case 0579, see Figure 7 page 203.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
73191 Retrosplenial area ventral part zone b/cInfralimbic area not presentbiotinylated dextran amine (BDA)
Collator note: see Table 1 page 200. RSPv shows no projections to PL or ILA, therefore it is inferred that neither of its suparts has projections towards these two targets. See also Figure 2C for a reconstruction of all injections in this article.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Two representative cases of a total of 12 injections confined to the RSv are depicted in Fig. 7A, B. Collator note: cases 0080 and 05079, Figure 7, page 204.

Details about the neuroanatomical projections from RSPv-b/c to PL

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
73193 Retrosplenial area ventral part zone b/cPrelimbic area not presentbiotinylated dextran amine (BDA)
Collator note: see Table 1 page 200. RSPv shows no projections to PL or ILA, therefore it is inferred that neither of its suparts has projections towards these two targets. See also Figure 2C for a reconstruction of all injections in this article.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Collator note: a compherensive set of small-sized injections was performed over the entire RSP, see Figure 2 page 198.

Details about the neuroanatomical projections from RSPv-b/c to RSPv-a

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71221 Retrosplenial area ventral part zone b/cRetrosplenial area ventral part zone a strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71222 Retrosplenial area ventral part zone b/cRetrosplenial area ventral part zone a strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71223 Retrosplenial area ventral part zone b/cRetrosplenial area ventral part zone a strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Two representative cases of a total of 12 injections confined to the RSv are depicted in Fig. 7A, B. Collator note: cases 0080 and 05079, Figure 7, page 204.

Details about the neuroanatomical projections from RSPv-b/c to RSPd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71226 Retrosplenial area ventral part zone b/cRetrosplenial area dorsal part strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71227 Retrosplenial area ventral part zone b/cRetrosplenial area dorsal part strongbiotinylated dextran amine (BDA)
In all cases, dense labeling of terminating fibers is seen in layers I, III and V of ACv, ACd and RSv itself, and in layers I and V of RSd (Table 1, Fig. 7AF).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Two representative cases of a total of 12 injections confined to the RSv are depicted in Fig. 7A, B. Collator note: cases 0080 and 05079, Figure 7, page 204.

Details about the neuroanatomical projections from RSPd to ILA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71228 Retrosplenial area dorsal partInfralimbic area not presentbiotinylated dextran amine (BDA)
Collator note: see Table 1, page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Seven animals with injections confined to the RSd were examined with two representative cases shown in Fig. 8A, B.

Details about the neuroanatomical projections from RSPd to PL

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71229 Retrosplenial area dorsal partPrelimbic area not presentbiotinylated dextran amine (BDA)
Collator note: see Table 1 page 200.
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Seven animals with injections confined to the RSd were examined with two representative cases shown in Fig. 8A, B.

Details about the neuroanatomical projections from RSPd to ACAd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71232 Retrosplenial area dorsal partAnterior cingulate area dorsal part strongbiotinylated dextran amine (BDA)
Following such injections, dense labeling is present in all layers of RSv (predominantly in I, IV, V), RSd (predominantly in I, II, V), ACv and ACd (predominantly in I and III; Table 1, Fig. 8C).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71233 Retrosplenial area dorsal partAnterior cingulate area dorsal part strongbiotinylated dextran amine (BDA)
Following such injections, dense labeling is present in all layers of RSv (predominantly in I, IV, V), RSd (predominantly in I, II, V), ACv and ACd (predominantly in I and III; Table 1, Fig. 8C).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Seven animals with injections confined to the RSd were examined with two representative cases shown in Fig. 8A, B.

Details about the neuroanatomical projections from RSPd to ACAv

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71230 Retrosplenial area dorsal partAnterior cingulate area ventral part strongbiotinylated dextran amine (BDA)
Following such injections, dense labeling is present in all layers of RSv (predominantly in I, IV, V), RSd (predominantly in I, II, V), ACv and ACd (predominantly in I and III; Table 1, Fig. 8C).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71231 Retrosplenial area dorsal partAnterior cingulate area ventral part strongbiotinylated dextran amine (BDA)
Following such injections, dense labeling is present in all layers of RSv (predominantly in I, IV, V), RSd (predominantly in I, II, V), ACv and ACd (predominantly in I and III; Table 1, Fig. 8C).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Seven animals with injections confined to the RSd were examined with two representative cases shown in Fig. 8A, B.

Details about the neuroanatomical projections from RSPd to RSPv-a

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71237 Retrosplenial area dorsal partRetrosplenial area ventral part zone a strongbiotinylated dextran amine (BDA)
Following such injections, dense labeling is present in all layers of RSv (predominantly in I, IV, V), RSd (predominantly in I, II, V), ACv and ACd (predominantly in I and III; Table 1, Fig. 8C).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71238 Retrosplenial area dorsal partRetrosplenial area ventral part zone a strongbiotinylated dextran amine (BDA)
Following such injections, dense labeling is present in all layers of RSv (predominantly in I, IV, V), RSd (predominantly in I, II, V), ACv and ACd (predominantly in I and III; Table 1, Fig. 8C).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71239 Retrosplenial area dorsal partRetrosplenial area ventral part zone a strongbiotinylated dextran amine (BDA)
Following such injections, dense labeling is present in all layers of RSv (predominantly in I, IV, V), RSd (predominantly in I, II, V), ACv and ACd (predominantly in I and III; Table 1, Fig. 8C).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Seven animals with injections confined to the RSd were examined with two representative cases shown in Fig. 8A, B.

Details about the neuroanatomical projections from RSPd to RSPd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71240 Retrosplenial area dorsal partRetrosplenial area dorsal part strongbiotinylated dextran amine (BDA)
Following such injections, dense labeling is present in all layers of RSv (predominantly in I, IV, V), RSd (predominantly in I, II, V), ACv and ACd (predominantly in I and III; Table 1, Fig. 8C).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71241 Retrosplenial area dorsal partRetrosplenial area dorsal part strongbiotinylated dextran amine (BDA)
Following such injections, dense labeling is present in all layers of RSv (predominantly in I, IV, V), RSd (predominantly in I, II, V), ACv and ACd (predominantly in I and III; Table 1, Fig. 8C).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71242 Retrosplenial area dorsal partRetrosplenial area dorsal part strongbiotinylated dextran amine (BDA)
Following such injections, dense labeling is present in all layers of RSv (predominantly in I, IV, V), RSd (predominantly in I, II, V), ACv and ACd (predominantly in I and III; Table 1, Fig. 8C).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Seven animals with injections confined to the RSd were examined with two representative cases shown in Fig. 8A, B.

Details about the neuroanatomical projections from RSPd to RSPv-b/c

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
71234 Retrosplenial area dorsal partRetrosplenial area ventral part zone b/c strongbiotinylated dextran amine (BDA)
Following such injections, dense labeling is present in all layers of RSv (predominantly in I, IV, V), RSd (predominantly in I, II, V), ACv and ACd (predominantly in I and III; Table 1, Fig. 8C).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71235 Retrosplenial area dorsal partRetrosplenial area ventral part zone b/c strongbiotinylated dextran amine (BDA)
Following such injections, dense labeling is present in all layers of RSv (predominantly in I, IV, V), RSd (predominantly in I, II, V), ACv and ACd (predominantly in I and III; Table 1, Fig. 8C).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
71236 Retrosplenial area dorsal partRetrosplenial area ventral part zone b/c strongbiotinylated dextran amine (BDA)
Following such injections, dense labeling is present in all layers of RSv (predominantly in I, IV, V), RSd (predominantly in I, II, V), ACv and ACd (predominantly in I and III; Table 1, Fig. 8C).
Jones B.F., Groenewegen H.J. & Witter M.P., 2005
General description technique/protocol: Seven animals with injections confined to the RSd were examined with two representative cases shown in Fig. 8A, B.